Abstract

BackgroundThe prevalence of diffuse-type gastric cancer (GC), especially signet ring cell carcinoma (SRCC), has shown an upward trend in the past decades. This study aimed to develop computed tomography (CT) based radiomics nomograms to distinguish diffuse-type and SRCC GC preoperatively.MethodsA total of 693 GC patients from two centers were retrospectively analyzed and divided into training, internal validation and external validation cohorts. Radiomics features were extracted from CT images, and the Lauren radiomics model was established with a support vector machine (SVM) classifier to identify diffuse-type GC. The Lauren radiomics nomogram integrating radiomics features score (Rad-score) and clinicopathological characteristics were developed and evaluated regarding prediction ability. Further, the SRCC radiomics nomogram designed to identify SRCC from diffuse-type GC was developed and evaluated following the same procedures.ResultsMultivariate analysis revealed that Rad-scores was significantly associated with diffuse-type GC and SRCC (p < 0.001). The Lauren radiomics nomogram showed promising prediction performance with an area under the curve (AUC) of 0.895 (95%CI, 0.957–0.932), 0.841 (95%CI, 0.781–0.901) and 0.893 (95%CI, 0.831–0.955) in each cohort. The SRCC radiomics nomogram also showed good discrimination, with AUC of 0.905 (95%CI,0.866–0.944), 0.845 (95%CI, 0.775–0.915) and 0.918 (95%CI, 0.842–0.994) in each cohort. The radiomics nomograms showed great model fitness and clinical usefulness by calibration curve and decision curve analysis.ConclusionOur CT-based radiomics nomograms had the ability to identify the diffuse-type and SRCC GC, providing a non-invasive, efficient and preoperative diagnosis method. They may help guide preoperative clinical decision-making and benefit GC patients in the future.

Highlights

  • Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related death worldwide [1]

  • Clinical characteristics, including tumor location, differentiation status, Borrmann type, levels of CEA and CA199, and TNM stages were significantly different between intestinal-type and diffuse-type gastric cancer (GC) patients

  • Feature selection and construction of the Lauren radiomics support vector machine (SVM) model A total of 9691 features were extracted from the tumor region of interest (ROI) with satisfactory interobserver and intraobserver reproducibility assessments (Additional file 1: S8)

Read more

Summary

Introduction

Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related death worldwide [1]. Chen et al Journal of Translational Medicine (2022) 20:38 signet ring cell carcinoma (SRCC) [2]. The Lauren classification divides GC into intestinal-type, diffuse-type and mixed-type according to the histological morphology and cell characteristics of GC [5]. According to the WHO classification system, GC with at least 50% signet-ring cells (SRC) in the pathological specimen is defined as SRCC [6]. All SRCCs are classified as Lauren diffuse type [7,8,9], they have distinct etiology, pathogenesis, prognosis and tumor biological behavior, such as lymph node metastasis rate, chemosensitivity [10,11,12,13,14,15]. The prevalence of diffuse-type gastric cancer (GC), especially signet ring cell carcinoma (SRCC), has shown an upward trend in the past decades. This study aimed to develop computed tomography (CT) based radiomics nomograms to distinguish diffuse-type and SRCC GC preoperatively

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call